20311 ⎘
Medicinal preparations containing organic active ingredients; Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil Proline; Derivatives thereof, e.g. captopril
Minitablet, Preparation Method Thereof, and Formulation
#2BLOOD COAGULATION TIME SHORTENING AGENT FOR BLOOD SPECIMEN DEFICIENT IN COAGULATION FACTOR XII
#3Alkylphenyl Substituted Compounds, Compositions and Methods of Use
#4SUBSTITUTED 3-FLUOROBENZENEPROPANOATE COMPOUND AND PREPARATION METHOD THEREFOR, PHARMACEUTICAL COMPOSITION THEREOF, AND USE THEREOF
#5TRANSDERMAL DELIVERY FORMULATIONS
#6GLUCOSE-DEPENDENT INSULINOTROPIC POLYPEPTIDE RECEPTOR ANTAGONISTS AND USES THEREOF
#7COMPOSITIONS FOR DRINKING WATER
#8COMPOSITION FOR PROMOTING COLLAGEN PRODUCTION COMPRISING AMIDATED AMINO ACID
#9NOX INHIBITORS FOR USE IN THE TREATMENT OF ALPORT SYNDROME
#10COMPOUNDS, COMPOSITIONS, AND METHODS FOR REDUCING PRODUCTION OF TRIMETHYLAMINE
#11PYRROLES AND IMIDAZOLES AS BET PROTEIN INHIBITORS
#12APROCITENTAN FOR THE TREATMENT OF HYPERTENSION
#13COMPOSITIONS AND METHODS FOR TREATING SOLID CANCER
#14METHODS FOR THE PREVENTION OR TREATMENT OF LEFT VENTRICLE REMODELING
#15COMPOSITIONS FOR PREVENTING TRANSITION FROM ACUTE TO CHRONIC PAIN
#16MODULATORS OF INTRACELLULAR CHLORIDE CONCENTRATION FOR USE IN THE TREATMENT OF COGNITIVE DECLINE
#17Compositions and Methods for Treatment of Edema
#18METHOD TO PREVENT AND TREAT GLAUCOMA BY CALCIUM CHANNEL BLOCKERS, ANGIOTENSIN CONVERTING ENZYME INHIBITORS, AND ANGIOTENSIN RECEPTOR BLOCKERS
#19COMPOSITIONS AND METHODS FOR THE TREATMENT OF ALZHEIMER'S DISEASE AND OTHER NEUROGENERATIVE DISEASE
#20NITROGEN-CONTAINING HETEROCYCLIC COMPOUNDS AND USES THEREOF
#21LISINOPRIL FORMULATIONS
#22EXTRACELLULAR VESICLES DERIVED FROM OSTEOBLAST LINEAGE CELLS FOR THERAPEUTIC AND DIAGNOSTIC USE
#23COMPOSITIONS AND METHODS TO POTENTIATE MUSCULOSKELETAL EFFECT OF ONE OR MORE ANABOLIC AMINO ACIDS ON BONE HEALTH
#24AMINO ACID COMPOSITIONS
#25AMINO ACID COMPOSITIONS
#26AMINO ACID COMPOSITIONS
#27AMINO ACID COMPOSITIONS
#28AMINO ACID COMPOSITIONS
#29AMINO ACID COMPOSITIONS
#30AMINO ACID COMPOSITIONS
#31METHODS OF TREATING CHRONIC KIDNEY DISEASE WITH DAPAGLIFLOZIN
#32BIOLOGIC ENHANCEMENT FORMULATION
#33SUBLINGUAL COMPOSITIONS FOR ERECTILE DYSFUNCTION
#34METHOD OF GLUCOSE-DEPENDENT INSULINOTROPIC POLYPEPTIDE (GIP) STABILIZATION
#35COLLAGEN HYDROLYSATE COMPOSITION FOR REDUCING JOINT PAIN AFTER EXERCISE
#36Nitrile-Containing Antiviral Compounds
#37Danegaptide Formulation for Application in the Eye
#38PHARMACEUTICAL COMPOUNDS AND METHODS OF MAKING AND USING THE SAME
#39Micronutrient composition to prevent and reverse protein glycation during oxidative stress in human
#40METHODS AND COMPOSITIONS FOR PROVIDING MYOCARDIAL PROTECTION AND TREATING MYOCARDIAL STRESS AND FIBROSIS
#41COMPOSITION
#42PROTEIN HYDROLYSATES
#43Carboxylic Acid Containing Indanyl Compounds for the Treatment of Neurodegenerative Diseases
#44TREATMENT OF HFPEF IN POST-MENOPAUSAL WOMEN WITH AN SGC STIMULATOR
#45Hepatitis B Antiviral Agents
#46METHODS, COMPOSITIONS AND DEVICES FOR TREATING CANCER WITH ILLUDOFULVENES
#47COMPOSITIONS AND METHODS FOR DIAGNOSING AND TREATING INFLAMMATORY CONDITIONS
#48PLANT ESSENTIAL OIL AMINO ACID COMPOSITION AND PREPARATION METHOD THEREFOR
#49Glycan-Interacting Compounds and Methods of Use
#50Compositions and Methods for Treating Spinal Cord Injury and Synaptic Dysfunction
#51COSMETIC COMPOSITIONS
#52COMPOSITION AND METHODS OF TREATMENT USING TRANSDERMAL SUPPLEMENTATION
#53COMPOSITIONS FOR ANTIHYPERTENSIVE DRUGS
#54PYRROLIDINE AMIDE DERIVATIVE SALT AND USE THEREOF
#55Lisinopril formulations
#56PARENTERAL NUTRITION CONTAINING TRACE ELEMENTS
#57METHODS OF TREATING CORONAVIRUS INFECTIONS BY CO-ADMINISTERING AN FKBP LIGAND AND AN ANTIVIRAL AGENT
#58COMBINATION TREATMENT FOR NETHERTON SYNDROME
#59Combination of AXL Antibodies and ACE Inhibitors in the Treatment of Fibrosis
#60EYE DROPS TO TREAT CHEMICALLY INDUCED CORNEAL DAMAGE
#61SMALL MOLECULE ALLOSTERIC MODULATORS OF CLASS B GPCR, THE PTHR, AND METHOD TO IDENTIFY THEM
#62METHOD FOR MODULATING THE AMOUNT OF VIRUS, METHOD FOR TREATING OR PREVENTING VIRUS INFECTIONS DISEASE, METHOD FOR ESTIMATING THE AMOUNT OF VIRUS, AND METHOD FOR PREDICTING THE PROGNOSIS OF VIRUS INFECTION DISEASE IN SUBJECT, AS WELL AS COMPOSITION AND SYSTEM FOR THE SAME
#63Livestock Feed
#64CARDIOVASCULAR DISEASE MEDICATION ADMINISTRATION METHODS
#65ENHANCED NITRATE COMPOSITIONS AND METHODS OF USE
#66ENHANCED NITRATE COMPOSITIONS AND METHODS OF USE
#67ENHANCED NITRATE COMPOSITIONS AND METHODS OF USE
#68ENHANCED NITRATE COMPOSITIONS AND METHODS OF USE
#69TREATMENT OF CENTRAL NERVOUS SYSTEM DISORDERS BY INTRANASAL ADMINISTRATION OF IMMUNOGLOBULIN G
#70Danegaptide for Use in the Treatment or Prevention of a Kidney Disease
#71MULTI-LIGAND DRUG CONJUGATES AND USES THEREOF
#72Methods Comprising Continuous Administration of a GLP-1 Receptor Agonist and Co-administration of a Drug
#73METHODS AND COMPOSITIONS FOR THE PREVENTION AND TREATMENT OF FRIEDREICH'S ATAXIA
#74COMPOSITIONS FOR TREATING FUNGAL AND BACTERIAL BIOFILMS AND METHODS OF USING THE SAME
#75Topical Hyperpigmentation Compositions and Method of Use
#76ORAL OCTREOTIDE THERAPY IN COMBINATION WITH DIGOXIN OR LISINOPRIL
#77USE OF SGLT-2 INHIBITORS FOR THE PREVENTION AND/OR TREAT-MENT OF CARDIAC DISEASES IN FELINES
#78Treatment for Diseases of Aging
#79GENETIC METHOD FOR DIAGNOSIS AND TREATMENT OF PRE AND POST CORONAVIRUS INFECTIONS
#80Lisinopril formulations
#81FERMENTED COMPOSITION
#82COMBINATION THERAPY FOR ALPORT RENAL DISEASE
#83Spirolactone compounds
#84Cosmetic compositions
#85METHODS OF NORMALIZING AMINO ACID METABOLISM
#86NUTRITION FORMULATION
#87Compositions and methods for treatment of edema
#88Hepatitis B antiviral agents
#89PHARMACEUTICAL COMBINATION COMPRISING A BRAIN AMINOPEPTIDASE A INHIBITOR, A DIURETIC AND A BLOCKER OF THE SYSTEMIC RENIN-ANGIOTENSIN SYSTEM
#90COMPOSITIONS AND METHODS FOR TREATING CORONAVIRUS
#91ORAL FORMULATIONS OF PYRROLIDINE DERIVATIVES
#92COMPOSITIONS AND METHODS THAT MODULATE VITAMIN D AND BONE MINERAL CONTENT IN A COMPANION ANIMAL
#93FORMULATIONS AND METHODS FOR TREATING DIARRHEA
#94COMBINATIONS OF NANOPARTICLE-ENCAPSULATED CARGO ENTITIES AND METHODS FOR MAKING AND USING SAME
#95COMPOSITION FOR PROMOTING BIOSYNTHESIS OF ELASTIN AND COLLAGEN IN CONNECTIVE TISSUE
#96Nitrile-Containing Antiviral Compounds
#97PEPTIDES AND PHARMACEUTICAL, NUTRACEUTICAL OR VETERINARY COMPOSITIONS FOR HAIR LOSS PREVENTION AND/OR TREATMENT
#98METHODS AND COMPOSITIONS FOR THE TREATMENT OF HEMANGIOMA
#99METHOD TO PREVENT AND TREAT MACULAR DEGENERATION BY CALCIUM CHANNEL BLOCKERS, ANGIOTENSIN CONVERTING ENZYME INHIBITORS, AND ANGIOTENSIN RECEPTOR BLOCKERS
#100STABLE PEPTIDE FORMULATIONS FOR ORAL USE
#101DEUTERIUM-ENRICHED SUBSTITUTED PHENOXYPHENYL ACETIC ACIDS AND ACYLSULFONAMIDES
#102CHEMOTHERAPEUTIC DRUG IMPLANT
#103NUTRITIONAL POWDER COMPRISING OLIGOPEPTIDES AND APPLICATIONS THEREOF
#104PROCESSES FOR GENERATING SUPERIOR ANTI-TUMOR T-CELL EFFECTOR AND MEMORY CELLS
#105Compositions for the treatment of epithelial lesions
#106APPLICATION OF COMPOUND AMINO ACIDS IN PREPARATION OF MEDICAMENT FOR IMPROVING SENSITIVITY OF BACTERIA TO ANTIBIOTICS
#107AUTOMATED SYSTEM AND METHOD TO PRIORITIZE LANGUAGE MODEL AND ONTOLOGY PRUNING
#108TREATMENT OF METABOLIC DISORDERS IN CANINE ANIMALS
#109MODIFIED RELEASE ORALLY ADMINISTERED AMINO ACID FORMULATIONS
#110PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING SARCOPENIA, CONTAINING UNNATURAL AMINO ACID
#111COMPOSITIONS AND METHODS FOR TREATING SPINAL CORD INJURY AND SYNAPTIC DYSFUNCTION
#112INDENYL COMPOUNDS, PHARMACEUTICAL COMPOSITIONS, AND MEDICAL USES THEREOF
#113SMALL MOLECULE INHIBITORS FOR TREATING CANCER IN A SUBJECT HAVING TUMORS WITH HIGH INTERSTITIAL PRESSURE
#114HAIR GROWING AGENT AND FOOD OR BEVERAGE PRODUCT COMPRISING SAME
#115Automated system and method to prioritize language model and ontology expansion and pruning
#116AMINO ACID TRANSPORT INHIBITORS AND THE USES THEREOF
#117METHODS FOR THE PREVENTION OR TREATMENT OF LEFT VENTRICLE REMODELING
#118Membrane Active Molecules
#119Compositions for treating fungal and bacterial biofilms and methods of using the same
#120Enzyme And Application Thereof
#121METHODS FOR ADMINISTERING ANGIOTENSIN II BY MONITORING RENIN LEVELS
#122SS-31 FOR THE PREVENTION AND/OR TREATMENT OF ANEURYSM
#123PROTEIN HYDROLYSATES
#124Nitrile-containing antiviral compounds
#125Plant virus particles for delivery of antimitotic agents
#126THERAPEUTIC COMBINATIONS
#127COMPOSITIONS AND METHODS FOR TREATING SCHISTOSOMA INFECTIONS
#128THIOL AND DISULFIDE-CONTAINING AGENTS FOR INCREASING MEIBOMIAN GLAND LIPID SECRETION
#129ORAL OCTREOTIDE THERAPY IN COMBINATION WITH DIGOXIN OR LISINOPRIL
#130USES OF A2 DOMAIN OF VON WILLEBRAND FACTOR
#131COMPOSITIONS AND METHODS TO POTENTIATE MUSCULOSKELETAL EFFECT OF ONE OR MORE ANABOLIC AMINO ACIDS ON BONE HEALTH
#132PARENTERAL NUTRITION FORMULATION WITH OPTIMIZED AMINO ACID AND GLUCOSE CONTENT
#133Nitrile-containing antiviral compounds
#134Dental Local Anesthetic Solution
#135ANTI-FIBROTIC NEU3 INHIBITOR COMPOUNDS AND METHODS OF USE
#136INJECTABLE COMPOSITION FOR INDUCING LIPOLYSIS AND METHOD USING THE SAME
#137Biosensing platform for detecting viral infections and methods for screening a modulator of viral infections and protecting therefrom
#138Compositions of Glycerol and /or Non-Toxic Amino Acids for Inhibiting and Destroying Biofilm, including Related Methods
#139Lisinopril formulations
#140INHIBITORS OF JUN N-TERMINAL KINASE
#141Lisinopril compositions with an ingestible event marker
#142Deep wrinkle vanishing compositions
#143ENALAPRIL FORMULATIONS
#144Methods, compositions and devices for treating cancer with illudofulvenes
#145PROPHYLACTIC AGENT FOR SPONTANEOUS CANCERS
#146KIDNEY-TARGETING DRUG DELIVERY CARRIER
#147Methods of treating chronic kidney disease with dapagliflozin
#148Methods of treating chronic kidney disease with dapagliflozin
#149SYNBIOTIC COMPOSITION FOR TREATMENT OF INFECTIONS IN ALLERGIC PATIENTS
#150THERAPEUTIC COMBINATIONS OF TDFRPs AND ADDITIONAL AGENTS AND METHODS OF USE
#151PARENTERAL NUTRITION CONTAINING TRACE ELEMENTS
#152Composition for treating burn wounds
#153Amino acid compositions and methods for treating cystic fibrosis
#154Methods and compositions for enhancing synthesis secretion and transport of collagen to increase wound strength
#155COMBINATION THERAPIES FOR TREATMENT OF INFLAMMATORY DISEASES
#156METHOD TO PREVENT AND TREAT GINGIVAL RECESSION BY CALCIUM CHANNEL BLOCKERS, ANGIOTENSIN CONVERTING ENZYME INHIBITORS, AND ANGIOTENSIN RECEPTOR BLOCKERS
#157METHOD TO PREVENT AND TREAT HEARING LOSS BY CALCIUM CHANNEL BLOCKERS, ANGIOTENSIN CONVERTING ENZYME INHIBITORS, AND ANGIOTENSIN RECEPTOR BLOCKERS
#158STABLE PHARMACEUTICAL COMPOSITIONS FOR PRESSURIZED METERED DOSE INHALERS
#159Enalapril formulations
#160METHOD TO PREVENT AND TREAT OCULAR CATARACT BY CALCIUM CHANNEL BLOCKERS, ANGIOTENSIN CONVERTING ENZYME INHIBITORS, AND ANGIOTENSIN RECEPTOR BLOCKERS
#161Method to prevent and treat macular degeneration by calcium channel blockers, angiotensin converting enzyme inhibitors, and angiotensin receptor blockers
#162METHOD TO PREVENT AND TREAT OSTEOARTHRITIS BY CALCIUM CHANNEL BLOCKERS, ANGIOTENSIN CONVERTING ENZYME INHIBITORS, AND ANGIOTENSIN RECEPTOR BLOCKERS
#163Hepatitis B antiviral agents
#164Use of SGLT-2 inhibitors for the prevention and/or treatment of cardiac diseases in felines
#165Enalapril formulations
#166Methods comprising continuous administration of exenatide and co-administration of a drug
#167Hepatitis B antiviral agents
#168Methods for treating heart disease in a subject with Friedreich's ataxia by an aromatic-cationic peptide
#169AMINO ACID COMPOSITION FOR ENABLING FULFILMENT OF THE AMINO ACID REQUIREMENTS OF A MONOGASTRIC ANIMAL SUCH AS A HUMAN OR A PIG
#170CARDIOPROTECTIVE AMINO ACID FORMULATION
#171Lisinopril formulations
#172Small molecule inhibitors of the nuclear translocation of androgen receptor for the treatment of castration-resistant prostate cancer
#173Use of sGC stimulators for the treatment of mitochondrial disorders
#174Metakaryocidal Treatments
#175METHODS OF TREATING NEUROPATHIC PAIN
#176Spirolactone compounds
#177N-(3-(2-(4-CHLOROPHENOXY)ACETAMIDO)BICYCLO[1.1.1] PENTAN-1-YL)-2-CYCLOBUTANE-1- CARBOXAMIDE DERIVATIVES AND RELATED COMPOUNDS AS ATF4 INHIBITORS FOR TREATING CANCER AND OTHER DISEASES
#178Inhibitors of metallo-beta-lactamases
#179Enalapril formulations
#180(R)-4-(1-(1-(4-(trifluoromethyl)benzyl)pyrrolidine-2-carboxamide)cyclopropyl)-benzoic acid as EP4 receptor antagonist
#181EYE DROPS TO TREAT CHEMICALLY INDUCED CORNEAL DAMAGE
#182METHODS FOR THE TREATMENT AND PREVENTION OF RENAL DISORDERS AND FATTY LIVER DISORDERS
#183COMPOSITIONS FOR TREATMENT OF ANNULAR SPINAL DISC INJURY
#184METHODS OF TREATING MYELOPROLIFERATIVE DISORDERS
#185COMPOSITIONS FOR PROLONGING THE SURVIVAL AFTER ORTHOTOPIC AND HETEROTOPIC XENOGENEIC HEART, KIDNEY, LUNG OR LIVER TRANSPLANTATIONS
#186Treatment of central nervous system disorders by intranasal administration of immunoglobulin g
#187METHODS FOR TREATING ALOPECIA AND ACHROMOTRICHIA
#188SYSTEMS AND METHODS TO TREAT PAIN LOCALLY
#189NEW USE
#190Pharmaceutical or cosmetic composition for preventing or treating hair loss or promoting hair growth
#191Compositions and methods for treatment of edema
#192Method for administration
#193Parenteral nutrition formulation with optimized amino acid and glucose content
#194METHODS FOR PREVENTION AND TREATMENT OF UROGENITAL ATROPHY OF MENOPAUSE BY CONTACT VASODILATORS
#195Cosmetic compositions
#196SULFAMOYL-ARYLAMIDES AND THE USE THEREOF AS MEDICAMENTS FOR THE TREATMENT OF HEPATITIS B
#197Plant virus particles for delivery of antimitotic agents
#198Enalapril formulations
#199Selective androgen receptor modulators (SARMs) and uses thereof
#200Orodispersible film composition comprising enalapril for the treatment of hypertension in a pediatric population
#201Phosphonium-based ionic drug conjugates
#202Anti-hypertensive and cholesterol-lowering fixed-dose combination and method of manufacture
#203Materials and methods for inhibiting tumor growth
#204Methods for the regulation of matrix metalloproteinase expression
#205FLUORENE COMPOUND AND PHARMACEUTICAL USE THEREOF
#206Amino acid compositions
#2077-dehydrocholesterol derivatives and methods using same
#208Targeting Macrophages to Modulate Electrical Conduction in the Heart
#209Enalapril formulations
#210Oral formulations of pyrrolidine derivatives
#211INHIBITORS OF JUN N-TERMINAL KINASE
#212COMPOSITIONS AND METHODS FOR TREATING ALOPECIA
#213COMPOSITIONS AND METHODS FOR TREATING ALOPECIA
#214SULFAMOYL-ARYLAMIDES AND THE USE THEREOF AS MEDICAMENTS FOR THE TREATMENT OF HEPATITIS B
#215THERAPEUTIC COMBINATIONS
#216Lisinopril formulations
#217KIDNEY-TARGETING DRUG DELIVERY CARRIER
#218Compositions and methods for preventing/treating metabolic syndrome
#219Method of treating or preventing Ras-mediated diseases
#220Indenyl compounds, pharmaceutical compositions, and medical uses thereof
#221Indenyl compounds, pharmaceutical compositions, and medical uses thereof
#222Enhanced Nitrate Compositions and Methods of Use
#223Stable, highly pure L-cysteine compositions for injection and methods of use
#224Compositions for treating fungal and bacterial biofilms and methods of using the same
#225LISINOPRIL FORMULATIONS
#226Hepatitis B antiviral agents
#227THIOL AND DISULFIDE-CONTAINING AGENTS FOR INCREASING MEIBOMIAN GLAND LIPID SECRETION
#228Treatment of metabolic disorders in canine animals
#229Amino acid compositions and their use for the treatment of traumatic brain injury
#230PAROXYSMAL EXTREME PAIN DISORDER TREATMENT
#231Betaine for the prevention of obesity
#232Method of glucose-dependent insulinotropic polypeptide (GIP) stabilization
#233METHOD FOR THE SYNTHESIS OF AN N-ACYL COMPOUND WITHOUT THE USE OF ORGANIC SOLVENT OR ACID CHLORIDE
#234METHODS AND COMPOSITIONS FOR REGULATING SRCA2A EXPRESSION LEVELS IN MYOCARDIAL INFARCTION
#235Methods for overcoming glucocorticoid resistance and for determining glucocorticoid resistance potential in cancer
#236Plant virus particles for delivery of antimitotic agents
#237PHARMACEUTICAL COMPOSITIONS WITH SYNCHRONIZED SOLUBILIZER RELEASE
#238Methods of normalizing amino acid metabolism
#239Compositions prepared from poultry and methods of their use
#240Composition for improving brain function
#241N-acetylated and non-acetylated dipeptides containing arginine to reduce the viscosity of viscous compositions of therapeutic polypeptides
#242Indenyl compounds, pharmaceutical compositions, and medical uses thereof
#243INHIBITORS OF JUN N-TERMINAL KINASE
#244SULPHAMOYLPYRROLAMIDE DERIVATIVES AND THE USE THEREOF AS MEDICAMENTS FOR THE TREATMENT OF HEPATITIS B
#245Indenyl compounds, pharmaceutical compositions, and medical uses thereof
#246Composition for improving joint function
#247Compositions and methods for treatment of edema
#248METHODS AND COLLAGEN PRODUCTS FOR TISSUE REPAIR
#249Feed composition for improving intraintestinal environment
#250Food for improving intraintestinal environment
#251METHODS AND COLLAGEN PRODUCTS FOR TISSUE REPAIR
#252Methods for treating Friedreich's ataxia by an aromatic-cationic peptide to increase frataxin protein levels
#253NOVEL ERYTHROMELALGIA TREATMENT
#254Liquid formulation
#255Inhibitors of hepatitis C virus
#256Poly(ketals) and related compositions and methods
#257METHODS FOR THE PREVENTION OR TREATMENT OF LEFT VENTRICLE REMODELING
#258Metakaryocidal Treatments
#259Natural compounds and fibrosis
#260METHOD FOR ADMINISTRATION
#261Composition and Methods for Treating Chronic Kidney Disease
#262ACTIVATION OF THE ENDOGENOUS ILEAL BRAKE HORMONE PATHWAY FOR ORGAN REGENERATION AND RELATED COMPOSITIONS, METHODS OF TREATMENT, DIAGNOSTICS, AND REGULATORY SYSTEMS
#263Dose and regimen for HDM2-p53 interaction inhibitors
#264Methods for treating pulmonary fibrosis
#265Fine-tune modulators of neuronal excitability for neuropsychiatric disorders
#266NOVEL DOSAGE REGIMEN
#267PROTEIN HYDROLYSATES
#268COMPOSITIONS AND METHODS FOR TREATING ALOPECIA
#269Lisinopril compositions with an ingestible event marker
#270COMPOSITIONS AND METHODS FOR TREATING ALOPECIA
#271BICYCLIC ARYL SPHINGOSINE 1-PHOSPHATE ANALOGS
#272Lisinopril formulations
#273INHIBITORS OF JUN N-TERMINAL KINASE
#274Myeloperoxidase compositions and methods for inhibition of lipopolysaccharides and lipid A
#275FLUORENE COMPOUND AND PHARMACEUTICAL USE THEREOF
#276Promysalin analogues and methods of use thereof
#277Peptides and pharmaceutical, nutraceutical or veterinary compositions for hair loss prevention and/or treatment
#278Enalapril formulations
#279PROCESSES FOR GENERATING SUPERIOR ANTI-TUMOR T-CELL EFFECTOR AND MEMORY CELLS
#280Methods and compositions for preserving retinal ganglion cells
#281Hepatitis B antiviral agents
#282SYSTEMS AND METHODS TO TREAT PAIN LOCALLY
#283SYSTEMS AND METHODS TO TREAT PAIN LOCALLY
#284Enalapril formulations
#285Hepatitis B antiviral agents
#286TREATMENT OF CENTRAL NERVOUS SYSTEM DISORDERS BY INTRANASAL ADMINISTRATION OF IMMUNOGLOBULIN G
#287Peptide-based methods for treating neurological injury
#288Selective androgen receptor modulators (SARMs) and uses thereof
#289Cosmetic compositions
#290Small molecule inhibitors of the nuclear translocation of androgen receptor for the treatment of castration-resistant prostate cancer
#291Inhibitors of hepatitis C virus
#292Methods for the regulation of matrix metalloproteinase expression
#293METHODS AND COMPOSITIONS FOR REGULATING SRCA2A EXPRESSION LEVELS IN MYOCARDIAL INFARCTION
#294Therapeutic combination and methods of treatment with a DLL4 antagonist and an anti-hypertensive agent
#295METHODS FOR THE TREATMENT AND PREVENTION OF RENAL DISORDERS AND FATTY LIVER DISORDERS
#296Combination therapy with nitrated lipids and inhibitors of the renin-angiotensin-aldosterone system
#297Complex of a glucopyranosyl derivative and preparation method and use thereof
#298Lisinopril formulations
#299Cooperative Medication Combination Systems
#300METHOD OF EVALUATING OR SELECTING ANDROGEN RECEPTOR ACTIVITY REGULATOR SELECTIVE TO SEBACEOUS GLANDS OR HAIR FOLLICLES